The activity of HSP90 seems to favor glycolysis in cancer cells, thus supplying increased intermediates such as lactate and acetyl-CoA, both of which can regulate gene expression by epigenetic modification [81,82,83]. The gene discussed is HSP90AB1; the disease is cancer.